Results 151 to 160 of about 45,032 (261)
Abstract A 6.5‐year‐old, spayed, female dog presented in acute respiratory distress. On admission, the dog exhibited dyspnoea, bradycardia, cyanosis and gastrointestinal signs, requiring immediate intubation and mechanical ventilation. Diagnostic evaluation revealed reduced butyrylcholinesterase activity, non‐cardiogenic pulmonary oedema, elevated ...
Sarah Hefer +6 more
wiley +1 more source
Cutaneous lupus erythematosus - from pathogenesis to targeted therapy. [PDF]
Klein B +3 more
europepmc +1 more source
Dyspigmentation and scarring in cutaneous lupus erythematosus. [PDF]
Chambers S +7 more
europepmc +1 more source
ABSTRACT Background Intense pulsed light (IPL) therapy is widely used for skin rejuvenation but frequently induces transient skin barrier impairment, erythema, and discomfort. Post‐procedure skincare targeting barrier repair and symptom relief remains a clinical priority.
Jianhua Zhang +4 more
wiley +1 more source
A Case Report of a Rare Subacute Cutaneous Lupus Erythematosus with Chin Prostration. [PDF]
Li W +6 more
europepmc +1 more source
Abstract Cryoglobulinemia (CG) is defined by the presence of serum immunoglobulins that precipitate below 37°C and redissolve upon rewarming. It is classified into three types based on immunoglobulin composition. Type I, a rare form, involves monoclonal IgM or IgG and is linked to lymphoproliferative disorders.
Anna Linda Zignego +7 more
wiley +1 more source
High-Frequency Ultrasonography in Cutaneous Lupus Erythematosus. [PDF]
Karasińska A +2 more
europepmc +1 more source
Ay et al. investigated the cellular mechanisms behind the role of lysophosphatidic acid (LPA) in FGF23 production. They revealed that LPA cooperates with 1,25‐dihydroxyvitamin D (1,25D), that is, the bioactive form of vitamin D known to stimulate FGF23 synthesis. This synergy entails MAPK signaling and the induction of the gene encoding the interleukin‐
Birol Ay +7 more
wiley +1 more source
Ashes to Rashes: An Exploration of the Intersection Between Smoking and Cutaneous Lupus Erythematosus. [PDF]
Homer RO +6 more
europepmc +1 more source
Focus on Interferon Signature in Cutaneous Lupus Erythematosus: Novel Therapies From Better Understanding of the Pathogenesis. [PDF]
Gao M, Zhang N, Xia Y.
europepmc +1 more source

